US medtech firms lauch first in Europe

What we had already noticed as a trend in June 2011, when attending a seminar on "Market Acces Germany", is being confirmed by Tom Sommer, CEO of MassMEDIC, the Massachusetts Medical Device Industry Council. He confirms the paralysing effect of FDA policies which are inciting US firms to launch their products in Europe, where the review process is more reliable and predictable (and as well much more cost-effective). Listen to the interview.